An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.
Inhibitors of the protease of HIV-1 have been used successfully for the treatment of HIV-1-infected patients and AIDS disease. We tested whether these protease inhibitory drugs exerted effects in addition to their antiviral activity. Here, we show in mice infected with lymphocytic choriomeningitis v...
Үндсэн зохиолчид: | André, P, Groettrup, M, Klenerman, P, de Giuli, R, Booth, B, Cerundolo, V, Bonneville, M, Jotereau, F, Zinkernagel, R, Lotteau, V |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
1998
|
Ижил төстэй зүйлс
-
Role of the proteasome and non proteasomal proteases in the generation of CTL epitopes.
-н: Cerundolo, V, зэрэг
Хэвлэсэн: (1998) -
Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopes.
-н: Kelleher, A, зэрэг
Хэвлэсэн: (2001) -
Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
-н: Gileadi, U, зэрэг
Хэвлэсэн: (1999) -
Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes.
-н: Klenerman, P, зэрэг
Хэвлэсэн: (1998) -
The HIV Protease Inhibitor Nelfinavir Downregulates Akt Phosphorylation by Inhibiting Proteasomal Activity and Inducing the Unfolded Protein Response
-н: Anjali K. Gupta, зэрэг
Хэвлэсэн: (2007-04-01)